EANS-General Meeting: Intercell AG / Resolutions of the General Meeting

--------------------------------------------------------------------------------
General meeting information transmitted by euro adhoc. The issuer is
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Intercell AG - Extraordinary General Meeting approved proposed merger
of equals with Vivalis SA to create Valneva SE

Summary of next steps to merger closing

Voting results of Intercell's Extraordinary Shareholders' Meeting as
of February 27, 2013

Report on the approval of the proposed merger

Vienna, February 27, 2013 - Intercell AG (Vienna Stock Exchange,
ICLL) today announced that all resolutions were approved by the
Extraordinary Shareholders' Meeting held today. A majority of 97.4%
of the represented share capital voted in favor of the merger to
create Valneva SE, a biotech leader in vaccines and antibodies. The
General Meeting of Vivalis SA will take place on March 7, 2013. As
previously announced, the merger is expected to close in May 2013,
after which Valneva SE intends to launch a EUR 40 million capital
increase, subject to regulatory approval.

A total of approximately 33.7% of the outstanding share capital of
Intercell AG was represented in the shareholders meeting.

The resolutions of the Extended Shareholder Meeting included:

*Resolution on the demerger *Resolution on the cross-border merger
*Resolution on the discharge of the members of the management board
for the period from January 1, 2012 to September 30, 2012 *Resolution
on the discharge of the members of the supervisory board for the
period from January 1, 2012 to September 30, 2012 *Resolution on the
remuneration of the members of the supervisory board for the period
from January 1, 2012 to September 30, 2012

For further details about the resolutions please see
www.intercell.com.

Further inquiry note:
Intercell AG
Nina Waibel
Corporate Communications
Tel. +43 1 20620-1222
communications@intercell.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: Intercell AG
Campus Vienna Biocenter 3
A-1030 Wien
phone: +43 1 20620-0
FAX: +43 1 20620-800
mail: investors@intercell.com
WWW: www.intercell.com
sector: Biotechnology
ISIN: AT0000612601
indexes: ATX Prime
stockmarkets: official market: Wien
language: English